A B S T R A C T Cholera enterotoxin inhibits the antigeninduced, IgE-mediated release of histamine from human leukocytes and the lysis of allogeneic mastocytoma cells by splenic lymphocytes from specifically immunized mice. This effect requires a prolonged preincubation time of the toxin with the lymphocyte/leukocyte preparations: a demonstrable inhibition requires about 30 min of preincubation and the toxin activity is still increasing at 90-180 min. Cholera enterotoxin also stimulates adenyl cyclase and leads to increased levels of cyclic AMP in the lymphocyte/leukocyte preparations. The concentration of toxin required for both cyclic AMP accumulation and inhibition of the biologic responses is about the same (ca. 1 ng/ml), and the time course of cyclic AMP accumulation parallels the development of inhibitory activity. Both activities, inhibition of the in vitro hypersensitivity reactions and cyclic AMP accumulation, are blocked by cholera antitoxin and by a toxoid prepared from the toxin (choleragenoid). These are specific antagonists in that they do not block the inhibiting activity or rise in cyclic AMP levels caused by other adenyl cyclase stimulators. Because cholera enterotoxin has no known activity other than the stimulation of adenyl cyclase and because of its unusual time course and the availability of specific antagonists, this data considerably
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In both model systems the measured changes in cyclic AMP correlated well with the relative inhibitory effects of the amines and prostaglandins studied. The evidence was circumstantial rather than conclusive, however, because in both cases the nucleotide was measured in a heterogeneous cell population, whereas histamine release or cytolytic activity involved a subpopulation of cells. In the case of human leukocytes, the histamine-containing basophils comprised less than 1% of the cells in which cyclic AMP was measured. The percentage of lymphocytes in mouse splenic-cell preparations was larger (> 80% of the leukocytes present), but the actual number of these lymphocytes involved in specific cytolytic activity was only of the order of 2-4% (11) .
Consequently, we have sought to design critical experiments which could disprove the hypothesis that cyclic AMP inhibits both immediate and cellular hypersensitivity reactions in vitro. For this purpose we used the enterotoxin of Vibrio cholerae, which stimulates adenyl cyclase activity and the production of cyclic AMP in many tissues (12) (13) (14) (15) , including gut mucosa, where this action is probably the pathogenic basis of cholera (16) .
We found that cholera enterotoxin stimulated cyclic AMP production and inhibited both histamine release In an accompanying paper we report further observations related to the unique mechanism of action of cholera enterotoxin, and results of experiments in which the toxin was used to test two other hypotheses that implicate cyclic AMP as a regulator of leukocyte function (17) . METHODS Histamine release. Leukocytes from donors sensitive to ragweed and grass were separated from the other formed elements of the blood by dextran sedimentation, washed several times, and resuspended in a serum-free Tris buffer containing calcium, magnesium, and crystallized human albumin.
The cells were then challenged with either antigen E of ragweed or grass group I antigen and the histamine released from these cells into the supernatant fluid measured by the fluorometric assay described by Shore et al. (18) (19) (20) . These techniques have previously been described in detail. We have currently used May's modification of our earlier method (21, 22) . All experimental points are carried out in duplicate; the values agree within ±5-10%o.
Lymphocytic-mediated cytolysis. The system employed was that originally described by 'Brunner, Mauel, Cerottini, and Chapuis (23) . Briefly, CmT BE mice were injected intraperitonally with 107 DBA/2 mastocytoma cells. 11 days later the immune mice were sacrificed, and splenic lymphoid cell suspensions prepared. 10,000,000 viable lymphocytes were incubated at 370C for varying periods of time with 10' 'Crlabeled mastocytoma cells. Total cytolysis was evaluated by measurement of 'Cr release and specific cytolysis by correction for the 'Cr released in the presence of 107 normal (i.e., nonimmune) CD7 B1 lymphocytes. These methods have previously been described in detail (11, 23) .
Cyclic AMP measurements. The method of Gilman was used (24) . Its application to the present systems has been described previously (4, 10) , and a modification of the extraction procedure is described in detail in the accompanying paper (17 Fig. 2a . The results are entirely concordant with the inhibition data: a definite effect is seen with concentrations as low as 0.1-0.3 ng/ml; 1 ng/ml provides a strong stimulus and the effect levels off at about 10 ng/ml as in the inhibition dose-response curves. Fig. 2b shows that the time course of cyclic AMP accumulation in the leukocytes after treatment with cholera enterotoxin is similar to the inhibition time course: little activity at 30 min and an increase which is still continuing at 90 min. The activity of cholera enterotoxin on cyclic AMP is potentiated by 10 In order to demonstrate the specificity of cholera enterotoxin its effects were blocked by first treating the cells with choleragenoid and with an antitoxin raised in dogs. In the experiments shown in Fig. 3a , cells were treated with 2.5 ng/ml of cholera enterotoxin together with varying levels of the toxoid. After 60 min preincubation, antigen was added. The toxin without toxoid caused, in these two cases shown, 80 and 84% inhibition; we have plotted the percent inhibition of toxin activity by the toxoid against the concentration of choleragenoid: 50% neutralization of toxin activity was noted at about 7 and 15 ng/ml of toxoid, a three-and sixfold multiple (by weight) of the toxin level used. A similar experiment carried out with the antitoxin is shown in Fig. 3b: 50%o inhibition was noted at a 1.5 and 3.0 X 10" dilution of the antiserum. The effects of choleragenoid and antitoxin on cyclic AMP accumulation in human leukocytes stimulated by cholera enterotoxin are shown in Fig. 4: 50% inhibition of the cyclic AMP increase is noted at about 10 ng/ml of toxoid and at a 2-3 X 10" dilution of the antitoxin. Further studies with the choleragenoid (not shown) indicate that it is specific for cholera toxin in the sense that it does not block the action of prostaglandin El or of isoproterenol. Similarly, the toxin is not affected by the beta blocker propranolol which inhibits the activity of isoproterenol.
Lymphocyte-mediated cytotoxicity. Lymphocyte-mediated cytolysis requires the specific interaction of two cell types: an effector lymphoid cell and an antigenbearing target cell. The destruction of target cells (as measured by "1Cr release) is a specific lytic event characterized kinetically by a linear destruction of target cells resulting from interactions of a single target cell with a single "sensitized" lymphocyte (a "one-hit destruction) (11) . Compared with the in vitro release of histamine, the destruction of target cells is a relatively slow process, somewhere between 1 and 2 h being required before specific cytolysis is demonstrable even at a ratio of 100 lymphocytes to each target cell. In spite of these vast kinetic differences, all of the cyclic AMP active agents studied thus far are similar in the two systems (10) . Isoproterenol, for example, has an effect which is rapidly dissipated in in vitro cytolysis inasmuch as the cyclic AMP levels rise and fall rapidly (17) . Cholera enterotoxin, however, proved to be a potent agent with a long lasting action. Preincubation of lymphocytes for 2 h with 0.1 ng/ml cholera enterotoxin inhibited, by approximately 50%, the subsequent specific cytolytic activity of the lymphoid cells (Fig. 5a ): This represents an inhibitory activity comparable with that shown by the toxin in the histamine-release system. The inhibition observed was not due to nonspecific toxicity of the cholera enterotoxin preparation. Trypan blue exclusion tests showed no decrease in viability of the lymphoid cell preparations after incubation with toxin. The time course of inhibition of cytolysis by cholera enterotoxin showed a delayed pattern which was similar to that observed in the immediate hypersensitivity reaction (Fig. Sa) . Measurement of the cyclic AMP accumulation in mouse splenic lymphocytes stimulated by cholera enterotoxin is shown in Fig. Sb ; again the data are concordant with those derived from inhibition studies, though the concentration of toxin required for a ineasurable cyclic AMP increase is slightly higher than that required for a discernible inhibition of target cell lysis.
Experiments devised to measure the effects of the choleragenoid preparation and the dog antitoxin on the inhibition of cytolysis shown by cholera enterotoxin are shown in Table I . As in the histamine-release assay, both agents, toxoid and antitoxin antibody, interfered with toxin-stimulated cyclic AMP accumulation, and prevented the inhibition of cytolysis shown by cholera toxin.
DISCUSSION
As far as is known, cholera enterotoxin has no activity other than that of stimulating adenyl cyclase and such toxicity as it engenders is presumably due to this action, which has been noted in every cell system thus far studied (12) . In addition to this broad range of activity, the protracted time necessary for its effect to become demonstrable is unique. Both characteristics make it an agent of considerable utility in attempting to analyze whether the cyclic AMP system plays a role in a particular process under study. Here we have demonstrated that the toxin inhibits both IgE-mediated histamine release and cell-mediated cytolysis and stimulates cyclic AMP accumulation in both preparations of cells used in these model systems, human leukocytes, and mouse lymphocytes. The concentration of toxin required for a measurable increase in the intracellular level of cyclic AMP is usually slightly higher than that needed to inhibit the in vitro model hypersensitivity reactions. This phenomenon has been noted with other agents in the two systems herein described, (4, 10) as well as in a variety of other situations (reference 1, p. 296). The explanation offered is that there is a discrepancy between the concentration of cyclic AMP required to lead a cell into a particular response (or lack thereof) and that which can be measured, with the former requiring a considerably lower concentration.
Cholera Toxin: Immediate and Delayed Hypersensitivity
We have previously shown that there is complete agreement between the effects of the catecholamine series (isoproterenol, epinephrine, norepinephrine, and phenylephrine) as to their known beta agonist activity, their inhibition of histamine release, and their stimulation of adenyl cyclase. The beta-blocker propranolol blocks both the inhibition of the allergic response and the cyclase stimulation. Similarly, in both hypersensitivity systems, the prostaglandin series, PGE1 and PGE2 and PGFla, shows complete concordance between the decreased immunologic response and increased cyclase activity (4, 10) . Kinetic studies with these agents, presented in the accompanying paper, are similarly in agreement (17) . With cholera enterotoxin acting on human leukocytes no effect on cyclic AMP is seen until about 30 min and the effect rises linearly at 60 and 90 min. Inhibition of histamine release after incubation of these cells with the toxin follows entirely similar kinetics. In cell-mediated specific immune cytolysis there is a linear rise with time in the cyclic AMP level and the inhibition of target cell lysis. These time course correlations add another dimension to the postulated causal association between increased cyclic AMP levels and in vitro manifestations of both immediate and delayed hypersensitivity.
The specificity of the response to cholera enterotoxin is amply demonstrated by the ability of the antitoxin and choleragenoid preparations to block the response. The action of the antitoxin is clear; it would appear from this work (seen also the following paper) that the toxoid competes with the toxin for cell receptor sites and thereby blocks its ability to stimulate cyclase.
It is perhaps curious that these two reactions should have such identical inhibition profiles. We feel this similarity is merely a reflection of the fact that both reactions are basically secretory in nature. This argument has been well-aired with respect to the IgE-mediated release of histamine (3): a similar conclusion with respect to the cell-mediated response appears to be tenable, based on the similarity in inhibition profiles. Further study is required to support this concept. Also to be established are the substance or substances "secreted" when sensitized lymphocytes are triggered by contact with homologous target cells, and how these act to kill the target cell. We do not doubt, however, that substantial differences in the mechanisms of the two reactions will come to light as they are further studied.
Finally, there is the question of how the cholera enterotoxin stimulates adenyl cyclase and why so much time is required. Experimental approaches to this problem are considered in the following report (17) .
